Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03556280 · ClinicalTrials.gov registry record · NA

Multi-Center Study of Sensory Stimulation to Improve Brain Function

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by Cognito Therapeutics.

Active
Registry status
NA
Development phase
60
Enrollment target
5
Study locations

NCT03556280 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that is active but no longer recruiting, run by Cognito Therapeutics. The registered enrollment target is 60 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03556280, a NA study of Alzheimer Disease and Mild Cognitive Impairment, is active but no longer recruiting, sponsored by Cognito Therapeutics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
5
Study locations

Study Summary

The Overture Study is a randomized, controlled, single-blind multi-center clinical trial using the GammaSense Stimulation system to study safety, tolerability, and efficacy in people with mild to moderate cognitive impairment.

Conditions Studied

Alzheimer Disease Mild Cognitive Impairment Dementia Cognitive Impairment Cognitive Decline Dementia Alzheimers Dementia, Mild Dementia of Alzheimer Type Dementia Alzheimer Type Cognitive Impairment, Mild

Interventions

  • DEVICE GammaSense Stimulation System (Active Settings)
  • DEVICE GammaSense Stimulation System (Sham Settings)

Study Locations (5)

Florida

  • Brain Matters Research - Delray Beach
  • Brain Matters Research - Stuart

Massachusetts

  • ActivMed Practices & Research, Inc - Methuen
  • Boston Center for Memory - Newton

New Jersey

  • The Cognitive and Research Center of New Jersey - Springfield

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-04-24
Est. Completion 2021-09
Phase NA

Sponsor

Cognito Therapeutics

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03556280

The ClinicalTrials.gov registry entry for NCT03556280 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Cognito Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which GammaSense Stimulation System (Active Settings) is the first listed.

NCT03556280 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, New Jersey.

Frequently Asked Questions

What is clinical trial NCT03556280 about?

NCT03556280 is a clinical study titled "Multi-Center Study of Sensory Stimulation to Improve Brain Function". The Overture Study is a randomized, controlled, single-blind multi-center clinical trial using the GammaSense Stimulation system to study safety, tolerability, and efficacy in people with mild to moderate cognitive impairment.

What is the current status of trial NCT03556280?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2018-04-24. Estimated completion is 2021-09.

What conditions does trial NCT03556280 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment, Dementia, Cognitive Impairment, Cognitive Decline.

What interventions are being tested in trial NCT03556280?

The interventions under investigation include: GammaSense Stimulation System (Active Settings) (DEVICE), GammaSense Stimulation System (Sham Settings) (DEVICE).

Who is sponsoring clinical trial NCT03556280?

This trial is sponsored by Cognito Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03556280 being conducted?

This trial has 5 study locations across Florida, Massachusetts, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Mild Cognitive Impairment

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.